A detailed history of Mas Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mas Advisors LLC holds 362 shares of LLY stock, worth $328,229. This represents 0.32% of its overall portfolio holdings.

Number of Shares
362
Holding current value
$328,229
% of portfolio
0.32%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $214,376 - $286,805
362 New
362 $281,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mas Advisors LLC Portfolio

Follow Mas Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mas Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mas Advisors LLC with notifications on news.